Activation of the anti-apoptotic Akt/protein kinase B pathway in human malignant gliomas in vivo

Anticancer Research

Volumn 22, Issue 5, 2002, Pages 2837-2840

  Schlegel, Jürgen ^a   Piontek, Guido ^a   Mennel, Hans Dieter ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Epidermal growth factor receptor; Glioma; MAP kinase; Protein kinase B; PTEN

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B;

ADULT; AGED; APOPTOSIS; ARTICLE; ASTROCYTOMA; CANCER CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVATION; FEMALE; GENE DELETION; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR BIOPSY;

ADULT; AGED; ASTROCYTOMA; BLOTTING, WESTERN; BRAIN NEOPLASMS; ENZYME ACTIVATION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 0036765422     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Schlegel J, Merdes A, Stumm G, Albert FK, Forsting M, Hynes NE and Kiessling M: Amplification of the epidermal growth factor receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer 56: 72-77, 1994.
2. Liu W, James CD, Frederick L, Alderete BE and Jenkins RB: PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res 57: 5254-7, 1997.
3. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP and Mak TW: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39, 1998.
4. Cantley LC and Neel BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A 96: 4240-5, 1999.
5. Bondeva T, Pirola L, Bulgarelli-Leva G, Rubio I, Wetzker R and Wymann MP: Bifurcation of lipid and protein kinase signals of P13Kgamma to the protein kinases PKB and MAPK. Science 282: 293-6, 1998.
6. Holland EC, Celestino J, Dai C, Schaefer L, Sawaya RE and Fuller GN: Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet 25: 55-7, 2000.
7. Cheney IW, Johnson DE, Vaillancourt MT, Avanzini J, Morimoto A, Demers GW, Wills KN, Shabram PW, Bolen JB, Tavtigian SV and Bookstein R: Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer. Cancer Res 58: 2331-4, 1998.
8. Wick W, Furnari FB, Naumann U, Cavenee WK and Weller M: PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis. Oncogene 18: 3936-43, 1999.
9. Razzini G, Berrie CP, Vignati S, Broggini M, Mascetta G, Brancaccio A and Falasca M: Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines. Faseb J 14: 1179-87, 2000.
10. Sambrook J, Frisch EF and Maniatis T: Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1989.
11. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshooth H, Wigler MH and Parsons R:PTEN, a putative protein tyrosine phosphotase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947, 1997.
12. Steck PA, Pershouse MA, Jasser SA, Yung WKA, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DHF and Tavtigian SV: Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nature Genet 15: 356-362, 1997.
13. Haas-Kogan D, Shalev N, Wong M, Mills G, Yount G and Stokoe D: Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC. Curr Biol 8: 1195-8, 1998.
14. Datta SR, Dudek H, Tao X, Masters S, Fu H, Gotoh Y and Greenberg ME: Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91: 231-41, 1997.
15. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96: 857-68, 1999.
16. Ozes ON, Mayo LD, Gustin JA, Pfeffer SR, Pfeffer LM and Donner DB: NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase [see comments]. Nature 401: 82-5, 1999.
17. Romashkova JA and Makarov SS: NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling [see comments]. Nature 401: 86-90, 1999.
18. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S and Reed JC: Regulation of cell death protease caspase-9 by phosphorylation. Science 282: 1318-21, 1998.
19. Teng DH, Hu R, Lin H, Davis T, IliEV D, Frye C, Swedlund B, Hansen KL, Vinson VL, Gumpper KL, Ellis L, El Naggar A, Frazier M, Jasser S, Langford LA, Lee J, Mills GB, Pershouse MA, Pollack RE, Tornos C, Troncoso P, Yung WK, Fujii G, Berson A, Steck PA et al.: MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines. Cancer Res 57: 5221-5, 1997.
20. Schlegel J, Piontek G, Budde B, Neff F and Kraus A: The Akt/protein kinase B-dependent anti-apoptotic pathway and the mitogen-activated protein kinase cascade are alternatively activated in human glioblastoma multiforme. Cancer Lett 158: 103-8, 2000.